Natus Medical Inc (BABY) : Moody Aldrich Partners scooped up 19,375 additional shares in Natus Medical Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 26, 2016. The investment management firm now holds a total of 34,760 shares of Natus Medical Inc which is valued at $1,390,400.Natus Medical Inc makes up approximately 1.11% of Moody Aldrich Partners’s portfolio.
Other Hedge Funds, Including , American Century Companies Inc sold out all of its stake in BABY during the most recent quarter. The investment firm sold 143,688 shares of BABY which is valued $5,747,520.Fisher Asset Management boosted its stake in BABY in the latest quarter, The investment management firm added 365 additional shares and now holds a total of 589,798 shares of Natus Medical Inc which is valued at $23,987,085. Natus Medical Inc makes up approx 0.05% of Fisher Asset Management’s portfolio.Bnp Paribas Arbitrage Sa boosted its stake in BABY in the latest quarter, The investment management firm added 5,643 additional shares and now holds a total of 10,316 shares of Natus Medical Inc which is valued at $409,029.
Natus Medical Inc closed down -0.24 points or -0.61% at $39.33 with 2,51,280 shares getting traded on Friday. Post opening the session at $39.55, the shares hit an intraday low of $39.2 and an intraday high of $39.72 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, Natus Medical Inc reported $0.39 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 20, 2016. Analyst had a consensus of $0.36. The company had revenue of $96.00 million for the quarter, compared to analysts expectations of $92.71 million. The company’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.34 EPS.
Natus Medical Incorporated (Natus) is a provider of newborn care and neurology healthcare products and services used for the screening diagnosis detection treatment monitoring and tracking of common medical ailments in newborn care hearing impairment neurological dysfunction epilepsy sleep disorders and balance and mobility disorders. The Company offers two product families: Neurology which includes products and services for diagnostic electroencephalography and long term monitoring intensive care unit monitoring electromyography sleep analysis intra-operative monitoring and diagnostic and monitoring transcranial doppler ultrasound technology; and Newborn Care which includes products and services for newborn care including hearing screening brain injury thermoregulation jaundice management and various disposable products as well as products for diagnostic hearing assessment for children through adult populations and others.